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Summary Introduction
Wilson disease (WD), an autosomal recessive disorder of
Wilson disease (WD) is an autosomal recessive disordercopper transport, is characterized by impaired biliary excre-
of copper transport, characterized by impaired incorpo-tion and by impaired incorporation of copper into cerulo-
ration of copper into ceruloplasmin and by impairedplasmin. Toxic accumulation of copper causes tissue dam-
excretion via the bile. The disease phenotype includesage, primarily in the liver, brain, and kidneys. The gene for
progressive liver degeneration and/or neurological im-WD (ATP7B) has been cloned, and the protein product is
pairment, frequently with kidney malfunction, as a re-predicted to be a copper-transporting P-type ATPase with
sult of toxic effects of accumulated copper in severalhigh amino acid identity with that for Menkes disease, an
tissues, principally the liver, brain, and kidneys (DanksX-linked disorder of copper transport. Mutation screening
1995). In most populations, WD has a prevalence ofÇ1in WD patients has led to the identiﬁcation of at least 40
in 30,000 and a corresponding carrier frequency of Ç1mutations. In addition, haplotype analysis using three di-
in 90 (Scheinberg and Sternlieb 1984). Treatment in-nucleotide-repeat markers, D13S314, D13S301, and
volves removal of excess copper by chelating agents,D13S316, has been a useful indicator of speciﬁc mutations.
such as penicillamine or trientine, or by the blocking ofWe have determined haplotypes for the patients and their
intestinal copper absorption with zinc salts.parents and sibs, in 21 unrelated WD families from Japan.
The gene defective in WD (ATP7B) has been isolatedTwenty-eight different haplotypeswere observed on 42WD
by use of YAC mapping on 13q14.3 (Bull et al. 1993),chromosomes. In all the patients, the ATP7B coding se-
on the basis of homology with the Menkes disease genequence, including the intron-exon boundaries, was screened
(ATP7A), which is defective in an X-linked disorder offor mutations, by SSCP, followed by direct-sequence analy-
copper transport (Chelly et al. 1993; Mercer et al. 1993;sis of the shifted fragments. We identiﬁed 13 mutations, of
Vulpe et al. 1993), and by use of data from a brain-which 11 mutations are novel, including 7 mutations—1
cDNA library that was being screened for amyloid-re-insertion, 4 deletions, and 2 missense mutations—in the
lated genes (Tanzi et al. 1993). The 7.5-kb mRNA tran-coding region. The mutations reported in previous studies
script is expressed predominantly in the liver and kid-are 2299insC and Arg778Leu. Two patients were shown to
neys, and a trace amount of message was detected in thehave the 2299insC mutation, which has occurred in many
heart, brain, lungs, muscle tissue, placenta, and pancreasdifferent haplotypes in several populations, indicating a mu-
(Bull et al. 1993). Characterization of the exon-introntation hot spot. Primer-extension analysis of ATP7BmRNA
structure reveals that ATP7B is organized into 22 exonshas revealed multiple transcription start sites. Four of the
spanning a DNA region of Ç100 kb (Petrukhin et al.novel mutations (three 1-bp changes and one 5-bp deletion)
1994; Thomas et al. 1995a). The predicted protein prod-occur in the 5 UTR and may result in altered expression
uct of ATP7B (designated as ‘‘ATP7B’’) belongs to aof the WD gene.
group of cation-transporting P-type ATPases and is ho-
mologous to the predicted protein product of the
Menkes disease gene (ATP7A) (Chelly et al. 1993; Vulpe
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putative ATP-binding domain, and the AMVGDGVND of these patients had liver disease), and 24% had an age
of onset of ú16 years (20% of these patients had liversequence that connects the ATP-binding domain to
transmembrane segments involved in ion binding and disease). The normal chromosomes analyzed were those
from the heterozygous parents of the patients.translocation (Bull et al. 1993; Tanzi et al. 1993). The
description of the intronic sequence ﬂanking each exon
Haplotype Analysis(Petrukhin et al. 1994; Thomas et al. 1995a) has allowed
rapid PCR-based screening to identify new WD muta- DNA from the parents and patients within each family
was analyzed to determine the marker haplotypes pres-tions. In addition, the identiﬁcation of closely spaced,
highly polymorphic DNA markers that span the WD ent on each WD and each normal chromosome. Haplo-
types were derived by use of three microsatellite markersregion has allowed haplotype analysis of WDDNA sam-
ples from different human populations (Petrukhin et al. (D13S301, D13S314, and D13S316) ﬂanking the WD
locus. These markers have been found to be close to the1993; Tanzi et al. 1993; Thomas et al. 1993, 1994).
Mutation screening in WD patients has led to the WD gene, in previously published studies (Petrukhin et
al. 1993; Thomas et al. 1993, 1994). The ampliﬁcationidentiﬁcation of at least 40 disease-speciﬁc mutations,
mostly in populations of European origin (Bull et al. of CA repeats in patient and in parent DNA was per-
formed by use of PCR with pairs of speciﬁc primers, as1993; Tanzi et al. 1993; Figus et al. 1995; Thomas et
al. 1995a, 1995b). The data published to date suggest described in previous studies (Thomas et al. 1994,
1995b). The analysis was carried out by PCR in 10-mlthat WD results from a limited number of frequent mu-
tations that are both common and population speciﬁc volumes containing 50 mM KCl; 10 mM Tris, pH 8.0;
10 mg BSA/ml; 1.5 mM MgCl2; 200 mM each of dCTP,and from a large number of rare mutations. The most
common mutation observed is His1069Gln, which has dGTP, and dTTP; 25 mM dATP; 0.2 mCi [a-35S]-dATP;
and 0.5 units AmpliTaq (Perkin Elmer). Ampliﬁcationoccurred in the eastern and northern European popula-
tions, in which it accounts for Ç30% of the WD chro- was performed in a programmable thermal controller
(MJ Research PTC-100-96V), for 30 cycles of 30 s ofmosomes (Tanzi et al. 1993; Thomas et al. 1995a,
1995b). The other most frequent mutations are Arg- denaturation at 94C, 30 s of annealing at 58C, and
30 s of extension at 72C. The samples then were electro-778Leu, Arg778Gly, and 2299insC. Arg778Leu and
Arg778Gln have occurred at a higher frequency in the phoresed through 6% denaturing polyacrylamide gels,
which were dried and exposed to x-ray ﬁlm (X-omat;East Asian population (Chuang et al. 1996). The muta-
tion Arg778Gln has not been reported in a European Kodak) at room temperature for 1–5 days.
population. 2299insC has occurred in many populations
Detection of Mutationsand in several different haplotypes, suggesting a muta-
tion hot spot (Figus et al. 1995; Thomas et al. 1995b). Exons 1–21 of ATP7B were ampliﬁed by use of prim-
ers complementary to the DNA sequences ﬂanking theIn Japanese WD patients, a point mutation of a splice
acceptor site that is 5 bp upstream of the junction of exon-intron boundaries. The primers used for ampliﬁ-
cation of exons 2–21 and their product length are de-intron 4 and exon 5, resulting in the skipping of exon
5, has been reported (Shimizu et al. 1995). This study scribed elsewhere (Thomas et al. 1995a). The primers
used for ampliﬁcation of exon 1 were as described else-reports the results of haplotype analysis and mutation
screening performed on WD patients of Japanese de- where (Petrukhin et al. 1994). Exons were ampliﬁed
under conditions identical to those used for CA repeatsscent and the mapping of the transcription start site of
ATP7B. and were digested for 2 h with the appropriate restric-
tion enzyme (Thomas et al. 1995a). The samples then
were diluted with one volume of SSCP buffer (0.2 MSubjects and Methods
NaOH and 1% SDS) and three volumes of loading
Subjects buffer (95% formamide, 15 mM EDTA, and 0.03%
each of xylene cyanol and bromophenol blue), were de-DNA was isolated from peripheral blood (Miller et
al. 1988) collected from 21 unrelated Japanese families natured at 95C for 5 min, and were electrophoresed
through 6% nondenaturing polyacrylamide gels, underincluding 21 unrelated patients, 21 parents (from 11
families), and 7 unaffected sibs (from 6 families). There two different conditions—with 8% glycerol and with-
out glycerol—at room temperature for 18–24 h at 10was no known consanguinity between the parents of
each patient. These patients were mainly from the Ku- W before drying and exposure to x-ray ﬁlm (X-Omat;
Kodak). Patient DNA exhibiting shifts relative to nor-mamoto, Osaka, and Sendai regions of Japan. Diagnosis
of WD was based on low ceruloplasmin and copper mal samples, as detected by SSCP analysis, was directly
sequenced to identify the mutation. Patient DNA sam-serum concentrations, high urinary copper, and high
hepatic copper content. The age at onset of each patient ples that did not exhibit shifts relative to normal sam-
ples, as detected by SSCP analysis, for exons 5, 7, andwas within the range of 4–21 years. Seventy-six percent
of the patients had an age at onset of õ16 years (81% 8 were directly sequenced for detection of mutations.
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DNA from patients was ampliﬁed as described above
for 35 cycles with 200 mM of cold dATP and without
[a-35S]-dATP. Products were puriﬁed with a Qiaquick
spin column (Qiagen), were cycle sequenced (with Ther-
mosequanase; Amersham) by use of each of the PCR
primers, and were electrophoresed through 6% denatur-
ing polyacrylamide gels.
RNA Preparation and Primer-Extension Analysis
Total RNA was prepared from a human liver sample
by use of TRIzol Reagent (Gibco, BRL), according to
the manufacturer’s recommendations. Yeast RNA (Am-
bion) was used as a negative control in this experiment.
Ten mg of total RNA were mixed with [g-32P]-ATP end-
labeled primers, and the mixtures were heated at 70C
for 10 min and were snap chilled on ice. The primers
then were extended for 50 min at 42C with Super-
ScriptII reverse transcriptase, according to the manufac-
turer’s recommendations (Gibco, BRL). The antisense
primers, Ex1a and Ex1b (ﬁg. 1B), were derived from
sequence analysis of the ATP7B cDNA (Petrukhin et al.
1994). After cDNA synthesis, the DNA:RNA hybrid
was digested with RNAse A (Boehringer Mannheim),
and the primer-extended products were analyzed on a
6% denaturing polyacrylamide gel. A dideoxy chain ter-
mination sequence ladder derived from direct sequenc-
ing, by use of primer Ex1a, of a cosmid clone containing
the 5-most region of ATP7B, including exon 1, was
loaded next to the extension products in order to map
precisely the transcription initiation sites.
Figure 1 A, Primer-extension analysis. Ten mg of total RNA
from a human liver sample (lane 1) and from yeast (lane 2) each wereResults
annealed to the end-labeled primer Ex1a and were extended with
Haplotype Analysis reverse transcriptase. The primer-extended products were analyzed
on a 6% denaturing polyacrylamide gel. The predominant extensionHaplotypes of the markers D13S301–D13S314–
products (208 bp, 226 bp, and 243 bp) are indicated by horizontalD13S316 were constructed for 21 normal and 42 WD lines to the right of the ﬁgure, and a dideoxy chain termination se-
chromosomes (table 1). We detected 28 different haplo- quence ladder is marked ‘‘TCGA.’’ B, Nucleotide sequence of the 5
types associated with WD chromosomes. Haplotypes end of ATP7B. Transcription start sites are indicated by bent arrows.
The major start site is also indicated by ‘‘/1.’’ Primers Ex1a and Ex1b5–7–5.5 and 11–4–7 are the most common, each being
are the antisense sequences of the italicized bases. The boldface TTCobserved in 9.5% of the WD chromosomes. Haplotype
triplet of this sequence corresponds to the ﬁrst triplet of the previously5–7–5.5 was also observed in 9.5% of the normal chro- reported ATP7B cDNA sequence (Petrukhin et al. 1994). The transla-
mosomes analyzed. tion start site is underlined. The intronic sequence is shown in lower-
case letters.
Mutation Screening
We identiﬁed 13 mutations, of which 11 are novel
and 2 have been described elsewhere (Thomas et al. samples, as detected by SSCP analysis. The insertion and
deletion mutations cause a frameshift and are predicted1995a) (table 2). The mutations reported elsewhere are
2299insC and Arg778Leu. The novel mutations include to alter the reading frame of ATP7B, which would result
either in the absence of the protein product or in theseven mutations—one insertion, four deletions, and two
missense mutations—in the coding region, and four mu- production of a shortened nonfunctional protein. The
identiﬁed missense mutations reside in the Tm 4 andtations (three 1-bp changes and one 5-bp deletion) are
in the 5 UTR of ATP7B. The 13 mutations identiﬁed Tm 6 regions and in the phosphorylation domain. All
of these mutations are nonconservative and changeaccount for 60% of the WD chromosomes analyzed by
SSCP. We did not detect additional mutations, with di- amino acid residues as follows: a basic for a neutral
hydrophobic residue (Arg778Leu), a neutral cyclic for arect sequencing of exons 5, 7, and 8, in patient DNA
samples that did not exhibit shifts relative to normal neutral hydrophobic residue (Pro992Leu), and a neutral
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Table 1 an unknown mutation. Homozygotes were detected for
the following mutations: 2299insC, Pro992Leu, and
Haplotypes of WD and Normal Chromosomes in Japanese Families
delAGCCG 138 bp upstream of the translation start
site. Mutations usually were linked to a single speciﬁcNO. (%) OF
CHROMOSOMES haplotype. However, mutations 2299insC and Arg-
HAPLOTYPE, BY MARKER LOCUS 778Leu were found on several different haplotypes (ta-
WD Normal ble 2). Arg778Leu is the most common mutation,
D13S314 D13S301 D13S316 [n Å 42] [n Å 21]
accounting for 12% of the WD chromosomes. Homozy-
gotes were identiﬁed for haplotypes 1–7–4, 6–9–4, and1 3 4 1 (2.4) . . .
1 4 7 1 (2.4) . . . 7–7–7, which were associated with the following muta-
1 5 7 2 (4.8) . . . tions: delAGCCG 138 bp upstream of the translation
1 7 4 2 (4.8) 3 (14.3) start site, Pro992Leu, and 2299insC, respectively.
3 3 4 1 (2.4) . . .
3 5 7 . . . 1 (4.8)
Mapping of Transcription Start Sites of ATP7B3 6 5.5 1 (2.4) . . .
3 7 7 1 (2.4) . . . Primer-extension analysis of the total RNA obtained
3 7 9.5 1 (2.4) . . . from a human liver sample (ﬁg. 1A, lane 1) and of the
3 8 3 . . . 1 (4.8) total RNA from yeast (ﬁg. 1A, lane 2) were annealed to
3 8 4 1 (2.4) 1 (4.8)
end-labeled primer Ex1a (ﬁg. 1B), and the primer was3 9 4 . . . 1 (4.8)
extended with reverse transcriptase. The predominant5 5 6 1 (2.4) . . .
5 7 4 2 (4.8) . . . extension products were 208 bp, 226 bp, and 243 bp.
5 7 5 1 (2.4) . . . In addition to these extension products, smaller prod-
5 7 5.5 4 (9.5) 2 (9.5) ucts were also observed. These smaller products may
5 7 7 1 (2.4) . . .
reﬂect either multiple start sites that are often observed5 7 8 1 (2.4) . . .
in the GC-rich promoters or artifacts resulting from re-5 8 7 . . . 1 (4.8)
6 3 10 . . . 1 (4.8) verse-transcriptase termination in the GC-rich region.
6 4 4 . . . 1 (4.8) The positions of transcription start sites were conﬁrmed
6 9 4 3 (7.1) 1 (4.8) by use of a second primer, Ex1b (ﬁg. 1B), for which the
6 11 4 . . . 1 (4.8)
sequence is located 64 bp 5 of primer Ex1a. This primer7 7 7 2 (4.8) . . .
generated three predominant extension products that7 8 7 1 (2.4) . . .
10 5 5.5 1 (2.4) . . . map to positions identical to those generated with
11 3 7 1 (2.4) . . . primer Ex1a (data not shown).
11 4 4 2 (4.8) 1 (4.8)
11 4 6 1 (2.4) . . .
11 4 7 4 (9.5) . . . Discussion
11 5 7 1 (2.4) 3 (14.3)
11 5 9 . . . 1 (4.8) In this study, we have characterized mutations and
11 6 5.5 1 (2.4) . . . deﬁned respective haplotype associations, in 21 WD pa-
11 7 5.5 1 (2.4) . . . tients of Japanese origin. In WD, haplotype data has
11 7 7 2 (4.8) 1 (4.8)
been useful in mutation detection, since each haplotype11 8 4 1 (2.4) . . .
generally is associated with a speciﬁc mutation (Figus et
al. 1995; Thomas et al. 1995b; Loudianos et al. 1996).
We have detected 28 different haplotypes associatedpolar for a neutral hydrophobic residue (Gly1035Val).
with the 42 WD chromosomes. Haplotypes 5–7–5.5None of the missense mutations were seen among the
and 11–4–7 are the most common, each being observed21 normal chromosomes analyzed.
in 9.5% of WD chromosomes. Haplotype 5–7–5.5 was
DNA Polymorphisms also observed in 9.5% of the normal chromosomes
We have identiﬁed four sequence changes in the WD analyzed. The haplotype data suggest the presence in
gene that do not modify the amino acid sequence of the Japanese patients of many uncommon mutations. The
protein product or that are detected in normal chromo- mutation analysis detected 13 mutations, of which 11
somes of the same population or in chromosomes with are novel and 2 have been described elsewhere (Thomas
deﬁned disease-causing mutations (table 3). These vari- et al. 1995a). The novel mutations include ﬁve
ants have been considered polymorphisms. The variant frameshift and two missense mutations in the coding
3903/6TrC has been described elsewhere (Thomas et region and four mutations (three 1-bp changes and one
al. 1995a). 5-bp deletion) in the 5 UTR, of the WD gene. No analy-
Haplotype Association of WD Mutations sis of mutations in this region has been reported pre-
viously. The frameshift mutations are predicted to alterMost of the patients investigated are presumed to be
compound heterozygotes for an identiﬁed mutation and the reading frame of the WD gene, which would result
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Table 2
Mutations Detected in WD Chromosomes
Frequency of
Associated WD
Chromosomes Patient
Mutation Sequencea Haplotype(s) Exon Domain (%) Location
Frameshift:
1292delGT CTGTT 11–4–4 3 Copper 5 2.4 Osaka
2004delGAT TGATC 11–4–7 7 Tm 1 2.4 Osaka
2164insT CTCTG . . .b 8 Tm 3 2.4 Japan
2203del29 CT..TTC . . .b 8 Tm 3 2.4 Kumamoto
2299insC CGCCC 7–7–7, 7–8–7 8 Tm 4 7.1 Kumamoto
2871delC CCCAA 11–5–7 13 Cation channel/Tm 6 2.4 Tokyo
Missense:
Arg778Leu CGGTG 5–5–6, 5–7–4 8 Tm 4 12 Kumamoto
5–7–5, 5–7–5.5 Osaka
5–7–7 Niigata
Pro992Leu GCCCA 6–9–4 13 Cation channel/Tm 6 4.8 Osaka
Gly1035Val TGGCG . . .b 14 Phosphorylation 2.4 Japan
Putative regulatory:c
75ArC ACACC 11–7–5.5 1 5 UTR 2.4 Niigata
78ArC CACGC 1–7–4 1 5 UTR 7.1 Miyagi
128CrA CGCGC 1–7–4 1 5 UTR 7.1 Osaka
138delAGCCG AGCCGA 1–7–4 1 5 UTR 4.8 Osaka
a Altered sequences are underlined.
b No parental DNA samples were available to associate the mutations with the haplotypes.
c Nucleotides are numbered as 5 upstream of the translation start site.
either in the absence of the protein product or in the Pro992Leu occurs in the Tm 6 domain and in the pre-
dicted cation channel. This mutation is predicted to dis-production of a shortened nonfunctional protein. Evi-
dence for the morbidity of the missense mutations came rupt the function of the cation channel and/or the forma-
tion of the transmembrane domain. For the Arg778Leufrom several sources—the recurrence among WD pa-
tients, the failure to observe these mutations in normal mutation, the conclusion in favor of a disease-causing
defect is supported by the description of another aminochromosomes, the nonconservative nature of the substi-
tution, and the occurrence of mutations at conserved acid substitution, Arg778Gln, at the same position in
patients of Taiwanese origin (Chuang et al. 1996) andresidues in the regions of predicted functional impor-
tance. The mutations Gly1035Val and Pro992Leu occur of Arg778Gly in Sardinian patients (Figus et al. 1995).
These ﬁndings indicate the critical role of arginine atat highly conserved amino acid residues in the Menkes
and in other P-type ATPases (Bull et al. 1993). The position 778 for the function of Tm 4. We have identi-
ﬁed Arg778Leu and 2299insC to be the most commonGly1035Val mutation is located four amino acids 5
to the phosphorylation site DKTGT. The mutation mutations in our study group, representing 12% and
Table 3
Probable Polymorphisms
FREQUENCY OF
ASSOCIATED
CHROMOSOMES
(%)
POLYMORPHISM EXON DOMAIN EVIDENCE WD Normal
Leu770Leu 8 Tm 4 No amino acid change 7.1 4.8
Lys831Arg 10 Transduction Found in normal chromosomes 2.4 9.5
Ala1063Val 14 Phosphorylation Found in normal chromosomes 2.4 4.8
3903/6TrC 19 Intronic sequence Found in normal chromosomes 4.8 4.8
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vided by the Canadian Genetic Diseases Network of the Net-7.1%, respectively, of the mutations in the WD chromo-
works of Centre of Excellence.somes. Mutation 2299insC has been observed on two
different haplotypes (10–3–8 and 12–4–7) in the
northern European population (Thomas et al. 1995b)
and on several other haplotypes, including 10–17–5
and two other haplotypes in the Mediterranean popula- References
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